Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cyclosporine
Drug ID BADD_D00551
Description Cyclosporine is a calcineurin inhibitor known for its immunomodulatory properties that prevent organ transplant rejection and treat various inflammatory and autoimmune conditions. It is isolated from the fungus _Beauveria nivea_.[A174049] Initially manufactured by Sandoz and approved for use by the FDA in 1983, cyclosporine is now available in various products by Novartis (previously known as Sandoz).[L11097,L3734,L11118]
Indications and Usage For treatment of transplant (kidney, liver, and heart) rejection, rheumatoid arthritis, severe psoriasis.
Marketing Status Prescription; Discontinued
ATC Code L04AD01; S01XA18
DrugBank ID DB00091
KEGG ID D00184
MeSH ID D016572
PubChem ID 5280754
TTD Drug ID D0O3YF
NDC Product Code 55486-1604; 55486-1602; 11014-0041; 68084-879; 51927-0160; 59573-0001; 0093-9020; 60505-0133; 60505-4630; 52972-0027; 55486-1603; 55361-0025; 0093-5742; 55361-0022; 55361-0023; 0074-5503; 55361-0026; 10702-808; 0074-3108; 11014-0040; 0093-5740; 10888-5040; 47335-506; 0023-9163; 50090-1242; 68084-921; 0078-0241; 0074-3109; 55500-0009; 0078-0110; 0093-5741; 65897-1008; 10888-5041; 0378-8760; 47335-507; 51552-0663; 0078-0274; 68254-2501; 51862-460; 55486-1567; 65086-001; 0074-7269; 51927-0213; 60505-6202; 11014-0033; 60505-4631; 11014-0034; 60505-0134; 68254-0008; 0574-0866; 0172-7313; 66507-0001; 0078-0240; 50090-4476; 0078-0246; 0078-0248; 0093-9019; 63629-8640; 51927-3196; 0093-9018; 47848-004; 72969-017; 0078-0109; 0023-5301; 60505-4632; 51862-458; 52928-005
Synonyms Cyclosporine | Cyclosporine A | Cyclosporin A | Ciclosporin | Cyclosporin | Neoral | Sandimmun Neoral | CyA-NOF | CyA NOF | Sandimmune | Sandimmun | CsA-Neoral | CsA Neoral | CsANeoral | OL 27-400 | OL 27 400 | OL 27400
Chemical Information
Molecular Formula C62H111N11O12
CAS Registry Number 59865-13-3
SMILES CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C (C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C C(C)C)C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionT-cell surface glycoprotein CD3 epsilon chainA6H6M1Not Available2246324; 2738100; 8880225; 8288727; 2515162; 6831033; 3871216; 1950737; 2548278; 2846698; 3262683; 7759599; 9869836; 2211719; 3131638; 2809200; 2540100; 9287244; 12082550; 7535569
Bladder perforationvon Willebrand factorP04275T233488249125; 9352228; 9414275; 8589211; 9241755; 7544037; 9351387; 7586318; 2470733; 8615807; 11230807
Bone density decreasedOsteocalcinP02818Not Available8864416; 11303710; 9141540; 11012914; 11446565; 9514219; 9933485
Bone density decreasedParathyroid hormoneP01270T987088864416; 11303710; 9141540; 11012914; 11446565; 9514219; 9933485
ComaGamma-aminobutyric acid receptor subunit beta-1P15431Not Available10465348; 15730878; 10686090; 6694095
Complications of transplanted kidneyvon Willebrand factorP04275T233488249125; 9352228; 9414275; 8589211; 9241755; 7544037; 9351387; 7586318; 2470733; 8615807; 11230807
EncephalopathyGamma-aminobutyric acid receptor subunit beta-1P15431Not Available10465348; 15730878; 10686090; 6694095
Haemolysisvon Willebrand factorP04275T233488249125; 9352228; 9414275; 8589211; 9241755; 7544037; 9351387; 7586318; 2470733; 8615807; 11230807
HypertensionEndothelin-1P05305T2507610930191; 9931093; 8986453
HypertensionNitric oxide synthase, endothelialP29474T0604610930191; 9931093; 8986453
HypertensionNeprilysinP08473T0540910930191; 9931093; 8986453
Nephropathy toxicCalcineurin subunit B type 1P63098Not Available8591053; 7694398; 7592869; 7533090; 7542793; 7524531; 7520696
Renal disorderGolgin subfamily A member 2Q08379Not Available9125798; 9987092; 9214404; 12166693; 7564111; 12099512; 12427154
Renal disorderTransforming growth factor beta-1 proproteinP01137T972579125798; 9987092; 9214404; 12166693; 7564111; 12099512; 12427154
SeizureGamma-aminobutyric acid receptor subunit beta-1P15431Not Available10465348; 15730878; 10686090; 6694095
ThrombosisThrombomodulinP07204T085831848730; 7878634
ThrombosisGuanine nucleotide-binding protein G(q) subunit alphaP50148T122901848730; 7878634
TremorGamma-aminobutyric acid receptor subunit beta-1P15431Not Available10465348; 15730878; 10686090; 6694095
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Diabetes mellitus14.06.01.001; 05.06.01.0010.002856%Not Available
Diabetes mellitus inadequate control14.06.01.004; 05.06.01.0040.000519%Not Available
Diarrhoea07.02.01.001--
Diffuse large B-cell lymphoma01.15.02.001; 16.28.02.0010.000135%Not Available
Diplopia17.17.01.005; 06.02.06.0020.001558%Not Available
Discomfort08.01.08.003--Not Available
Disorientation19.13.01.002; 17.02.05.015--Not Available
Disseminated intravascular coagulation24.01.01.010; 01.01.02.0020.000339%
Disseminated tuberculosis11.04.01.0010.000519%Not Available
Disturbance in attention17.03.03.001; 19.21.02.002--
Diverticulitis11.01.07.003; 07.10.02.0010.000203%Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Drug eruption23.03.05.001; 10.01.01.005; 08.01.06.015--Not Available
Drug hypersensitivity10.01.01.001--Not Available
Drug ineffective08.06.01.006--Not Available
Dry eye06.08.02.0010.013240%
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Duodenal ulcer07.04.02.0020.000779%
Dysarthria19.19.03.001; 17.02.08.001--
Dysgeusia07.14.03.001; 17.02.07.0030.002856%
Dyskinesia17.01.02.006--
Dysmenorrhoea21.01.01.002--
Dyspepsia07.01.02.001--
Dysphagia07.01.06.0030.005452%
Dysphonia22.02.05.005; 19.19.03.002; 17.02.08.004--
Dyspnoea22.02.01.004; 02.01.03.002--
Dyspnoea exertional22.02.01.005; 02.01.03.0030.001817%Not Available
Dysuria20.02.02.0020.001038%
Ear disorder04.03.01.001--Not Available
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 29 Pages